Abstract
We retrospectively reviewed medical records of 39 hematopoietic SCT (HSCT) recipients who presented at our hospital between 1 October 2009 and 31 January 2010 with the 2009 H1N1 influenza infection. The median age at presentation was 13.8 years (range: 3.3–56.9), infections developed at a median of 585 days (range: 0–2316) post transplant, the majority (n=27, 69%) occurred in allogeneic HSCT recipients, 12 (31%) patients were on immunosuppressive therapy and 12 (31%) had GVHD. Lower airway disease was present in 8 patients (21%). In total, 15 patients (39%) were hospitalized with a median duration of 4.5 days (range: 3–27 days) and 3 (8%) required mechanical ventilation; 2 of whom died.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
CDC. Hospitalized patients with novel influenza A (H1N1) virus infection—California. MMWR Morb Mortal Wkly Rep 2009; 58: 536–541.
CDC. 2009 Pandemic influenza A (H1N1) virus infections—Chicago, Illinois, April–July 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 913–918.
Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E et al. Pandemic (H1N1) 2009. Update 62 pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680–689.
CDC. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection—United States. MMWR Morb Mortal Wkly Rep 2009; 58: 941–947.
Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009; 302: 1896–1902.
Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302: 1872–1879.
Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362: 1708–1719.
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009; 361: 1935–1944.
Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A et al. Critically Ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009; 302: 1880–1887.
Michael B . The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol 2008; 143: 455–467.
Lee I, Barton TD . Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs 2007; 67: 1411–1427.
Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a Retrospective Study at a major cancer center. Medicine 2006; 85: 278–287.
Raboni SM, Nogueira MB, Tsuchiya LR, Takahashi GA, Pereira LA, Pasquini R et al. Respiratory tract viral infections in bone marrow transplant patients. Transplantation 2003; 76: 142–146.
Ljungman P . Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant 2001; 7 (Suppl): 5S–7S.
Nichols WG, Guthrie KA, Corey L, Boeckh M . Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300–1306.
Kharfan-Dabaja M, Velez A, Richards K, Greene J, Field T, Sandin R . Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol 2010; 91: 124–127.
Rozovski U, Herishanu Y, Gipstein L, Naparstek E . Fatal H1N1 influenza infection in an allo-SCT recipient. Bone Marrow Transplant 2010; 45: 1572–1573.
Abdel-Rahman F, Hussein A, Rihani R, Hlalah O, El Taani H, Sharma S et al. Bone marrow and stem cell transplantation at King Hussein cancer center. Bone Marrow Transplant 2008; 42 (Suppl 1): S89–S91.
Nitu ME, Eigen H . Respiratory Failure. Pediatr Rev 2009; 30: 470–478.
CDC. Surveillance for pediatric deaths associated with 2009 pandemic influenza A (H1N1) virus infection---United States, April–August 2009. MMWR Morb Mortal Wkly Rep 2009; 58: 941–947.
CDC. Interim recommendations for clinical use of influenza diagnostic tests during the 2009-10 influenza season September 29, 2009. (Accessed October 2, 2009 at http://www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm).
CDC. Interim guidance on infection control measures for 2009 H1N1 influenza in healthcare settings, including protection of healthcare personnel, October 14, 2009. (Accessed October 17, 2009 at http://www.cdc.gov/h1n1flu/guidance/ill-hcp.htm).
CDC. Update: infections with a swine-origin influenza A (H1N1) virus—United States and other countries, April 28, 2009. Morb Mortal Wkly Rep 2009; 58: 431.
CDC Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009–2010 season, September 22, 2009 (Accessed on October 2, 2009 at http://www.cdc.gov/h1n1flu/recommendations.htm).
CDC CDC protocol of realtime RTPCR for swine influenza A (H1N1).Geneva:World Health Organization April 28, 2009. (Accessed May 2, 2009 at http://www.who.int/csr/resources/publications/swineflu/CDCrealtimeRTPCRprotocol_20090428.pdf).
Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360: 2605–2615.
Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010; 60: 257–263.
CDC. Infections with a swine-origin influenza A (H1N1) virus—United States and other countries. MMWR Morb Mortal Wkly Rep 2009; 58: 431–433.
Hassan IA, Chopra R, Swindell R, Mutton KJ . Respiratory viral infections after bone marrow/peripheral stem-cell transplantation: the Christie hospital experience. Bone Marrow Transplant 2003; 32: 73–77.
Machado CM, Boas LS, Mendes AV, Santos MF, da Rocha IF, Sturaro D et al. Low mortality rates related to respiratory virus infections after bone marrow transplantation. Bone Marrow Transplant 2003; 31: 695–700.
Iwasenko JM, Cretikos M, Paterson DL, Gibb R, Webb SA, Smith DW et al. Enhanced diagnosis of pandemic (H1N1) 2009 influenza infection using molecular and serological testing in intensive care unit patients with suspected influenza. Clin Infect Dis 2010; 51: 70–72.
Acknowledgements
We acknowledge the King Hussein Cancer Foundation for their support to KHCC.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Rihani, R., Hayajneh, W., Sultan, I. et al. Infections with the 2009 H1N1 influenza virus among hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 46, 1430–1436 (2011). https://doi.org/10.1038/bmt.2010.329
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2010.329